RQI Cohen and outlines targeted highyield commercial real estate additions in its latest quarterly earnings report Telesat TSAT Stock Key Takeaways In Focus 20260420 Newmont Corp NEM Key Earnings Play to Watch Amid Elevated Gold Price Tailwinds OXSQG Oxford reports slight Q4 2025 earnings miss shares edge higher amid mild positive investor sentiment NEOV NeoVolta gains 554 percent on 2186 percent year over year Q1 2026 revenue growth despite wide EPS miss Diamondback Energy FANG Wall Street Bullish Sentiment Converges With Fundamental Earnings Strength Is Nuveen SP500 BXMX stock weaker than competitors BXMX Latest Quarter Earnings Nuveen SP500 posts solid covered call yields no reported EPS What is the growth outlook for Ready RC stock Momentum Building 20260420 Northrop Grumman Corporation NOC Poised for Upside Amid Escalating Middle East Geopolitical Risks and Upcoming Q1 Earnings Release Jazz JAZZ Stock Approaches Resistance Hovering 20260422 Is Freightos CRGO stock considered stable Q4 2025 EPS Exceeds Expectations Why Delta Air DAL Stock Is Falling Now Flirts with Support 20260420 EVGN Evogene reports wider than expected Q4 2025 loss and 309 percent year over year revenue drop shares hold steady TransUnion TRU Stock Price Action Weakens 20260420 Is Nexalin Technology NXL stock failing at resistance Nexalin Technology posts 48 EPS miss wider loss vs estimates ANVS Annovis Bio shares drop 387 after Q4 2025 wider loss misses analyst estimates by 114 SP Global SPGI Announces 2026 VirtualOnly Annual Shareholder Meeting Scheduled for May 20 GRAB Grab beats Q4 2025 EPS estimates by wide margin but shares drop 152 percent today PSMT PriceSmart posts Q1 2026 earnings beat 72 percent year over year revenue growth lifts shares modestly B Barrick reports 138 percent EPS beat for Q4 2025 shares jump 221 percent in todays trading AST Space ASTS Stock Why Cost Advantage Selloff Intensifies 20260420 MNTS Momentus shares drop 144 post Q3 2023 earnings despite posting a modest EPS beat versus consensus analyst estimates Quince Therapeutics QNCX Stock Worth Entering 693 20260420